ClinicalTrials.gg
CompletedNCT03382028DENEBO1Updated Dec 22, 2017

Development of Child With Equinus Deformity Idiopathic

An observational study in Equinus Deformity, sponsored by Rennes University Hospital. Completed at 1 site in France. Open to participants aged 2 Years to 15 Years. Per ClinicalTrials.gov, last updated 2017-12-22.

Sponsored by Rennes University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
112
Ages
2 Years to 15 Years
Sex
All
01

Study summary

Identification and characterization of the link between psychomotor development and the appearance of associated signs in children with "Equinus Deformity " considered isolated at birth.

Read the detailed description

The main objective of this study is to define the frequency of developmental abnormalities in children with "Equinus Deformity Idiopathic" compared to the general population

The secondary objective is to identify the prenatal and / or neonatal characteristics that could be predictive of the occurrence of developmental abnormalities in

Prenatal and postnatal follow-up data are derived from the child's medical file. To complete these data and after inclusion, parents of children carrying "Equinus Deformity Idiopathic" will be sent a questionnaire that assesses overall psychomotor development and lists the medical events since the birth of their child (scoliosis, epilepsy ...).

02

Conditions studied

  • Equinus Deformity

Browse trials for

Keywords

  • developmental abnormalities
  • psychomotor development
03

In context

Equinus Deformity

10 studies on the registry are indexed under Equinus Deformity; 3 are open to participants now.

Browse Equinus Deformity studies →

Lead sponsor

Rennes University Hospital is the lead sponsor of 451 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 15 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Children with Equinus Deformity

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children born between January 2002 and August 2015
  • Prenatal or postnatal diagnosis of idiopathic or syndromic Equinus Deformity
  • Followed by the pediatric orthopedic service of Rennes University Hospital
  • Parent having received the information on the protocol and having not expressed their opposition.

Exclusion criteria

Exclusion Criteria:

  • Parents opposing the study
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
112 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Frequency of developmental abnormalities (with the exception of Equinus Deformity) in children with Equinus Deformity idiopathic compared to the general population.

    Time frame: through study completion an average of 1 year

07

Study locations

1 site
  • Rennes University Hospital
    Rennes, 35000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2017 to primary completion in Aug 2017, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2017
First posted
Dec 22, 2017
StartActual
Jun 1, 2017
Primary completionActual
Aug 31, 2017
CompletionActual
Aug 31, 2017
Last update
Dec 22, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 22, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03382028
Responsible party
Sponsor
First posted
Dec 22, 2017
Start date
Jun 1, 2017
Primary completion
Aug 31, 2017
Completion
Aug 31, 2017
Last update
Dec 22, 2017

Study contacts

Laurent Pasquier
principal investigator · Rennes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion